BioHealth News

Montgomery County Economic Development Corporation President and CEO Bill Tompkins Plans to Step Down at the End of His Current Term

Montgomery County Economic Development Corporation President and CEO Bill Tompkins Plans to Step Down at the End of His Current Term

Montgomery County, MD — The Montgomery County Economic Development Corporation (MCEDC) announced that Bill Tompkins will step down as President & CEO when his…

Read More
Emmes Group Company, Essex Management Appoints David Loose as Chief Executive Officer

Emmes Group Company, Essex Management Appoints David Loose as Chief Executive Officer

ROCKVILLE, Md., Jan. 7, 2025 /PRNewswire/ -- Essex Management, an Emmes Group company and a leader in biomedical informatics and health information technology, is pleased to announce…

Read More
Why the DMV Region Is Thriving as a Hub for Startups and Innovation

Why the DMV Region Is Thriving as a Hub for Startups and Innovation

The Washington D.C., Maryland, and Virginia (DMV) region has quickly become one of the nation’s top destinations for startups and tech innovation. With over…

Read More
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax®

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax®

GAITHERSBURG, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the exercise of contract option and modification valued at…

Read More
IonQ Completes Acquisition of Qubitekk, Solidifying Leadership in Quantum Networking

IonQ Completes Acquisition of Qubitekk, Solidifying Leadership in Quantum Networking

COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ (NYSE: IONQ), a leader in the quantum computing and networking industry, today announced the completion of its acquisition of substantially…

Read More
I-Mab Focuses on Advancing Givastomig as Lead Cancer Therapy in Clinical Development

I-Mab Focuses on Advancing Givastomig as Lead Cancer Therapy in Clinical Development

ROCKVILLE, MD, Jan. 6, 2025 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the…

Read More
Building Montgomery County’s Future: Economic Growth and Innovation with MCEDC’s Bill Tompkins on BioTalk

Building Montgomery County’s Future: Economic Growth and Innovation with MCEDC’s Bill Tompkins on BioTalk

[vc_row type="in_container" full_screen_row_position="middle" column_margin="default" column_direction="default" column_direction_tablet="default" column_direction_phone="default" scene_position="center" text_color="dark" text_align="left" row_border_radius="none" row_border_radius_applies="bg" overlay_strength="0.3" gradient_direction="left_to_right" shape_divider_position="bottom" bg_image_animation="none"][vc_column column_padding="no-extra-padding" column_padding_tablet="inherit" column_padding_phone="inherit" column_padding_position="all" column_element_spacing="default" background_color_opacity="1" background_hover_color_opacity="1" column_shadow="none"…

Read More
MEDTECHDRIVE Q&A: Few medical devices are designed for children. An FDA-Children’s National collaboration aims to change that.

MEDTECHDRIVE Q&A: Few medical devices are designed for children. An FDA-Children’s National collaboration aims to change that.

Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the many challenges with developing devices for children…

Read More
Germantown’s Precigen Seeks FDA Approval with Priority Review for New Treatment for Recurrent Respiratory Papillomatosis in Adults

Germantown’s Precigen Seeks FDA Approval with Priority Review for New Treatment for Recurrent Respiratory Papillomatosis in Adults

Precigen has submitted a Biologics License Application (BLA) to the FDA, seeking priority review for PRGN-2012, which could become the first FDA-approved treatment for…

Read More
Advancing Biomedical Innovation: ARPA-H’s Transformative 2024 Highlights

Advancing Biomedical Innovation: ARPA-H’s Transformative 2024 Highlights

BHI is proud to support ARPA-H through its Partnership Intermediary Agreement (PIA), providing EIR commercialization services to advance groundbreaking technologies. Notably, BaySpec, one of…

Read More
Governor Moore Signs Executive Order to Bolster Maryland’s Economic Competitiveness

Governor Moore Signs Executive Order to Bolster Maryland’s Economic Competitiveness

DEC 20, ANNAPOLIS, MD — Governor Wes Moore today signed an executive order to strengthen Maryland’s business climate and catalyze more economic growth in the state. The…

Read More
Arnold Consultancy & Technology, LLC Awarded $357,000 Phase I Grant to develop a Health Economic Model Marketplace

Arnold Consultancy & Technology, LLC Awarded $357,000 Phase I Grant to develop a Health Economic Model Marketplace

National Cancer Institute (NCI) has awarded a $357,000 SBIR grant to Arnold Consultancy & Technology, LLC to develop an open source model marketplace. MIAMI…

Read More
Spotlighting Growth and Collaboration in Life Sciences—Insights from Rachel Rath, Head of JLABS @ Washington, DC

Spotlighting Growth and Collaboration in Life Sciences—Insights from Rachel Rath, Head of JLABS @ Washington, DC

BHI is excited to highlight Rachel Rath’s recent LinkedIn Post, where she reflects on her first 90 days as Head of JLABS @ Washington,…

Read More
Uncommon Cures and TASK Partner to Advance Clinical Trials for Orphan Drugs Across Europe and South Africa

Uncommon Cures and TASK Partner to Advance Clinical Trials for Orphan Drugs Across Europe and South Africa

Chevy Chase, MD, 2 December 2024 – Uncommon Cures®, a pioneering organization dedicated to accelerating the development of orphan drugs, has announced a strategic…

Read More
Children’s National SPARK Symposium and Ribbon-Cutting Launch

Children’s National SPARK Symposium and Ribbon-Cutting Launch

Children’s National Innovation Ventures is hosting the Symposium on Pediatric Medical Countermeasures (MCMs) and the SPARK for Innovations in Pediatrics Launch and Prize Competition—a…

Read More